Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis
Clinical trial NCT03902691 · COMPLETED
Trial details
- NCT number
- NCT03902691
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2021-02-28
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.